Q4 2024 · 13F-HR
Pivotal bioVenture Partners Investment Advisor LLCholdings as filed
Filed 2025-02-13 · accession 0001012975-25-000081
$148.1M
Reported value
11
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 92243G108 | PCVX | VAXCYTE INC | $57.6M | 38.9% | 703,834 | Common | SHARED |
| H5870P102 | OCS | OCULIS HOLDING AG | $29.5M | 20.0% | 1,737,696 | Common | SHARED |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $29.5M | 19.9% | 2,120,508 | Common | SHARED |
| 45790W108 | — | INOZYME PHARMA INC | $12.5M | 8.41% | 4,494,851 | Common | SHARED |
| 98937L105 | ZBIO | ZENAS BIOPHARMA INC | $6.0M | 4.07% | 736,645 | Common | SHARED |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $4.0M | 2.72% | 595,518 | Common | SHARED |
| 09077V100 | BIOA | BIOAGE LABS INC | $3.8M | 2.55% | 653,374 | Common | SHARED |
| 75120L100 | — | RALLYBIO CORP | $2.3M | 1.56% | 2,404,644 | Common | SHARED |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $1.0M | 0.69% | 1,891,467 | Common | SHARED |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $953,012 | 0.64% | 560,595 | Common | SHARED |
| 449778109 | IOBTQ | IO BIOTECH INC | $795,061 | 0.54% | 864,197 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.